Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1460-1466

  Akkina, S K ^a   Connaire, J J ^a   Israni, A K ^a   Snyder, J J ^b   Matas, A J ^a   Kasiske, B L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Graft survival; Hemodialysis; Kidney transplantation; Performance measure; Slow graft function

Indexed keywords

CREATININE;

ADULT; ARTICLE; DIALYSIS; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; CREATININE; DELAYED GRAFT FUNCTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MINNESOTA; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 66249143003     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02651.x     Document Type: Article

References (20)

1. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: A systematic review. Nephrol Dial Transplant 2008 23 : 2995 3003.
2. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997 63 : 968 974. (Pubitemid 27173019)
3. Cecka JM. The UNOS Scientific Regristry. In : Cecka JM, Terasaki PI eds). Clinical Transplants 1998. Los Angeles : UCLA Tissue Typing Laboratory, 1999 : 1 16.
4. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998 66 : 1697 1701. (Pubitemid 29034994)
5. Feldman HI, Gayner R, Berlin JA et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996 11 : 1306 1313. (Pubitemid 26241420)
6. Moreso F, Seron D, Gil-Vernet S et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999 14 : 930 935. (Pubitemid 29155149)
7. Quiroga I, McShane P, Koo DD et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006 21 : 1689 1696. (Pubitemid 44063135)
8. Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998 54 : 972 978. (Pubitemid 28397418)
9. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ. Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 2002 16 : 425 429. (Pubitemid 36004274)
10. Johnston O, O'kelly P, Spencer S et al. Reduced graft function (with or without dialysis) vs immediate graft function-a comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006 21 : 2270 2274. (Pubitemid 44295055)
11. Schnuelle P, Gottmann U, Koppel H et al. Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantation. Nephrol Dial Transplant 2007 22 : 235 245. (Pubitemid 46050350)
12. Humar A, Johnson EM, Payne WD et al. Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant 1997 11 : 623 627. (Pubitemid 27526814)
13. Kasiske BL, Johnson HJ, Goerdt PJ et al. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients. Am J Kidney Dis 1997 30 : 639 645. (Pubitemid 27465357)
14. Belitsky P, MacDonald AS, Cohen AD et al. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: A prospective randomized study. Transplant Proc 1991 23 (1 Pt 2 999 1000.
15. Lebranchu Y, Bridoux F, Buchler M et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant 2002 2 : 48 56.
16. Charpentier B, Rostaing L, Berthoux F et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003 75 : 844 851. (Pubitemid 36373458)
17. Kamar N, Garrigue V, Karras A et al. Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: A randomized, multicenter study. Am J Transplant 2006 6 (5 Pt 1 1042 1048. (Pubitemid 44356656)
18. Woo YM, Craig AM, King BB et al. Biocompatible membranes do not promote graft recovery following cadaveric renal transplantation. Clin Nephrol 2002 57 : 38 44. (Pubitemid 34071624)
19. Romao JE Jr., Abensur H, de Castro MC, Ianhez LE, Massola VC, Sabbaga E. Effect of dialyser biocompatibility on recovery from acute renal failure after cadaver renal transplantation. Nephrol Dial Transplant 1999 14 : 709 712.
20. Valeri A, Radhakrishnan J, Ryan R, Powell D. Biocompatible dialysis membranes and acute renal failure: A study in post-operative acute tubular necrosis in cadaveric renal transplant recipients. Clin Nephrol 1996 46 : 402 409. (Pubitemid 26421408)